TY - JOUR
T1 - Identifying outcomes important to patients with glomerular disease and their caregivers
AU - Carter, Simon A.
AU - Gutman, Talia
AU - Logeman, Charlotte
AU - Cattran, Dan
AU - Lightstone, Liz
AU - Bagga, Arvind
AU - Barbour, Sean J.
AU - Barratt, Jonathan
AU - Boletis, John
AU - Caster, Dawn
AU - Coppo, Rosanna
AU - Fervenza, Fernando C.
AU - Floege, Ju¨Rgen
AU - Hladunewich, Michelle
AU - Hogan, Jonathan J.
AU - Richard Kitching, A.
AU - Lafayette, Richard A.
AU - Malvar, Ana
AU - Radhakrishnan, Jai
AU - Rovin, Brad H.
AU - Scholes-Robertson, Nicole
AU - Trimarchi, He´Rnan
AU - Zhang, Hong
AU - Azukaitis, Karolis
AU - Cho, Yeoungjee
AU - Viecelli, Andrea K.
AU - Dunn, Louese
AU - Harris, David
AU - Johnson, David W.
AU - Kerr, Peter G.
AU - Laboi, Paul
AU - Ryan, Jessica
AU - Shen, Jenny I.
AU - Ruiz, Lorena
AU - Wang, Angela Yee Moon
AU - Lee, Achilles Hoi Kan
AU - Fung, Samuel
AU - Tong, Matthew Ka Hang
AU - Teixeira-Pinto, Armando
AU - Wilkie, Martin
AU - Alexander, Stephen I.
AU - Craig, Jonathan C.
AU - Tong, Allison
N1 - Publisher Copyright:
© 2020 by the American Society of Nephrology.
PY - 2020/5/7
Y1 - 2020/5/7
N2 - Background and objectives Shared decision making in patients with glomerular disease remains challenging because outcomes important to patients remain largely unknown. We aimed to identify and prioritize outcomes important to patients and caregivers and to describe reasons for their choices. Design, setting, participants, & measurements We purposively sampled adult patients with glomerular disease and their caregivers from Australia, Hong Kong, the United Kingdom, and the United States. Participants identified, discussed, and ranked outcomes in focus groups using the nominal group technique; a relative importance score (between zero and one) was calculated. Qualitative data were analyzed thematically. Results Across 16 focus groups, 134 participants (range, 19–85 years old; 51%women), including 101 patients and 33 caregivers, identified 58 outcomes. The ten highest-ranked out comes were kidney function(importance score of 0.42), mortality (0.29), need for dialysis or transplant (0.22), life participation (0.18), fatigue (0.17), anxiety (0.13), family impact (0.12), infection and immunity (0.12), ability to work (0.11), and BP (0.11). Three themes explained the reasons for these rankings: Constraining day-to-day experience, impaired agency and control over health, and threats to future health and family. Conclusions Patients with glomerular disease and their caregivers highly prioritize kidney health and survival, but they also prioritize life participation, fatigue, anxiety, and family impact.
AB - Background and objectives Shared decision making in patients with glomerular disease remains challenging because outcomes important to patients remain largely unknown. We aimed to identify and prioritize outcomes important to patients and caregivers and to describe reasons for their choices. Design, setting, participants, & measurements We purposively sampled adult patients with glomerular disease and their caregivers from Australia, Hong Kong, the United Kingdom, and the United States. Participants identified, discussed, and ranked outcomes in focus groups using the nominal group technique; a relative importance score (between zero and one) was calculated. Qualitative data were analyzed thematically. Results Across 16 focus groups, 134 participants (range, 19–85 years old; 51%women), including 101 patients and 33 caregivers, identified 58 outcomes. The ten highest-ranked out comes were kidney function(importance score of 0.42), mortality (0.29), need for dialysis or transplant (0.22), life participation (0.18), fatigue (0.17), anxiety (0.13), family impact (0.12), infection and immunity (0.12), ability to work (0.11), and BP (0.11). Three themes explained the reasons for these rankings: Constraining day-to-day experience, impaired agency and control over health, and threats to future health and family. Conclusions Patients with glomerular disease and their caregivers highly prioritize kidney health and survival, but they also prioritize life participation, fatigue, anxiety, and family impact.
UR - http://www.scopus.com/inward/record.url?scp=85084389065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084389065&partnerID=8YFLogxK
U2 - 10.2215/CJN.13101019
DO - 10.2215/CJN.13101019
M3 - Article
C2 - 32354728
AN - SCOPUS:85084389065
SN - 1555-9041
VL - 15
SP - 673
EP - 684
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 5
ER -